Comparing BTK and BCL-2 inhibitor outcomes in different CLL subgroups VJHemOnc – Video Journal of Hematology & HemOnc 5:00 3 years ago 478 Далее Скачать
Combining BTK and BCL-2 inhibitors for the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 130 Далее Скачать
BTK and BCL-2 inhibitor combination therapies in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:25 4 years ago 88 Далее Скачать
BTK and BCL2 inhibitor resistance in CLL: session highlights VJHemOnc – Video Journal of Hematology & HemOnc 3:12 2 years ago 134 Далее Скачать
Outcomes of CLL patients following treatment with a covalent BTK and BCL2 inhibitor VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 102 Далее Скачать
Outcomes for CLL Patients Treated with BTK inhibitor and BCL2 inhibitor - ASH 2021 CLL Society 4:21 1 year ago 85 Далее Скачать
Advances in BTK and BCL2 inhibitors for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:27 1 year ago 291 Далее Скачать
Understanding and overcoming resistance to BTK and BCL-2 inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 125 Далее Скачать
Outcomes & healthcare utilization cost of patients with CLL refractory to BTK and BCL-2 inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:25 1 year ago 47 Далее Скачать
Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 212 Далее Скачать
Outcomes of CLL Patients After Treatment with BTK & BCL2 Inhibitors - EHA 2022 CLL Society 7:35 1 year ago 91 Далее Скачать
CLL: The Current and Future Paradigms of BCL2 Inhibition Targeted Oncology 7:03 5 years ago 75 Далее Скачать
Evaluating the role of BTK inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:14 3 years ago 124 Далее Скачать
The importance of real-world data in CLL & efficacy of BTK and Bcl-2 inhibitors in the real world VJHemOnc – Video Journal of Hematology & HemOnc 1:45 2 years ago 52 Далее Скачать
Updates in CLL from EHA 2024: combinations of BTK and BCL2 inhibitors, BTK degraders, and more VJHemOnc – Video Journal of Hematology & HemOnc 11:55 6 months ago 639 Далее Скачать
Managing BCL2 Inhibitor AEs in Chronic Lymphocytic Leukemia Targeted Oncology 5:43 5 years ago 56 Далее Скачать
Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward? Medscape 21:28 6 months ago 15 Далее Скачать
Patient selection for BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:49 2 years ago 98 Далее Скачать
